Millennium Pharmacon (Indonesia) Market Value
| SDPC Stock | IDR 195.00 2.00 1.02% |
| Symbol | Millennium |
Millennium Pharmacon 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Millennium Pharmacon's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Millennium Pharmacon.
| 12/05/2025 |
| 03/05/2026 |
If you would invest 0.00 in Millennium Pharmacon on December 5, 2025 and sell it all today you would earn a total of 0.00 from holding Millennium Pharmacon International or generate 0.0% return on investment in Millennium Pharmacon over 90 days. Millennium Pharmacon is related to or competes with Bundamedik Tbk, Phapros Tbk, Itama Ranoraya, Mark Dynamics, and Diagnos Laboratorium. PT Millennium Pharmacon International Tbk distributes and trades in prescription medicine, non-prescription medicine, fo... More
Millennium Pharmacon Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Millennium Pharmacon's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Millennium Pharmacon International upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.3 | |||
| Information Ratio | 0.1144 | |||
| Maximum Drawdown | 45.0 | |||
| Value At Risk | (4.17) | |||
| Potential Upside | 3.89 |
Millennium Pharmacon Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Millennium Pharmacon's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Millennium Pharmacon's standard deviation. In reality, there are many statistical measures that can use Millennium Pharmacon historical prices to predict the future Millennium Pharmacon's volatility.| Risk Adjusted Performance | 0.1009 | |||
| Jensen Alpha | 0.6735 | |||
| Total Risk Alpha | 0.3958 | |||
| Sortino Ratio | 0.1816 | |||
| Treynor Ratio | (0.54) |
Millennium Pharmacon March 5, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1009 | |||
| Market Risk Adjusted Performance | (0.53) | |||
| Mean Deviation | 2.52 | |||
| Semi Deviation | 2.3 | |||
| Downside Deviation | 3.3 | |||
| Coefficient Of Variation | 813.93 | |||
| Standard Deviation | 5.24 | |||
| Variance | 27.45 | |||
| Information Ratio | 0.1144 | |||
| Jensen Alpha | 0.6735 | |||
| Total Risk Alpha | 0.3958 | |||
| Sortino Ratio | 0.1816 | |||
| Treynor Ratio | (0.54) | |||
| Maximum Drawdown | 45.0 | |||
| Value At Risk | (4.17) | |||
| Potential Upside | 3.89 | |||
| Downside Variance | 10.91 | |||
| Semi Variance | 5.3 | |||
| Expected Short fall | (4.25) | |||
| Skewness | 4.41 | |||
| Kurtosis | 28.47 |
Millennium Pharmacon Backtested Returns
As of now, Millennium Stock is very steady. Millennium Pharmacon has Sharpe Ratio of 0.04, which conveys that the firm had a 0.04 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Millennium Pharmacon, which you can use to evaluate the volatility of the firm. Please verify Millennium Pharmacon's Risk Adjusted Performance of 0.1009, downside deviation of 3.3, and Mean Deviation of 2.52 to check out if the risk estimate we provide is consistent with the expected return of 0.13%. Millennium Pharmacon has a performance score of 3 on a scale of 0 to 100. The company secures a Beta (Market Risk) of -1.17, which conveys a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Millennium Pharmacon are expected to decrease by larger amounts. On the other hand, during market turmoil, Millennium Pharmacon is expected to outperform it. Millennium Pharmacon right now secures a risk of 3.15%. Please verify Millennium Pharmacon International sortino ratio, maximum drawdown, and the relationship between the total risk alpha and treynor ratio , to decide if Millennium Pharmacon International will be following its current price movements.
Auto-correlation | 0.52 |
Modest predictability
Millennium Pharmacon International has modest predictability. Overlapping area represents the amount of predictability between Millennium Pharmacon time series from 5th of December 2025 to 19th of January 2026 and 19th of January 2026 to 5th of March 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Millennium Pharmacon price movement. The serial correlation of 0.52 indicates that about 52.0% of current Millennium Pharmacon price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.52 | |
| Spearman Rank Test | 0.0 | |
| Residual Average | 0.0 | |
| Price Variance | 34.08 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetOther Information on Investing in Millennium Stock
Millennium Pharmacon financial ratios help investors to determine whether Millennium Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Millennium with respect to the benefits of owning Millennium Pharmacon security.